XML 20 R5.htm IDEA: XBRL DOCUMENT v3.21.2
Condensed Consolidated Balance Sheets (Unaudited) - USD ($)
$ in Thousands
Oct. 31, 2021
Apr. 30, 2021
Current Assets:    
Cash and cash equivalents $ 4,715 $ 5,206
Restricted cash 817 525
Receivables, less allowance; $404; $636, on each respective date 37,069 32,882
Inventories 18,120 16,517
Income tax receivable 774 955
Prepaid expenses and other current assets 5,325 4,372
Total Current Assets 66,820 60,457
Property, plant and equipment, at cost 59,744 58,804
Accumulated depreciation (44,229) (42,822)
Net Property, Plant and Equipment 15,515 15,982
Right of use assets 8,454 9,279
Other assets 3,504 3,666
Total Assets 94,293 89,384
Current Liabilities:    
Short-term borrowings 13,695 6,828
Current portion of financing lease liability 22 21
Current portion of operating lease liabilities 1,356 1,348
Accounts payable 20,228 16,780
Employee compensation and amounts withheld 4,084 4,726
Deferred revenue 3,052 3,123
Other accrued expenses 1,334 1,355
Total Current Liabilities 43,771 34,181
Long-term portion of financing lease liability 80 91
Long-term portion of operating lease liabilities 7,031 7,860
Accrued pension and deferred compensation costs 4,563 4,652
Deferred income taxes 380 307
Other non-current liabilities 1,165 806
Total Liabilities 56,990 47,897
Commitments and Contingencies
Stockholders' Equity:    
Common stock, $2.50 par value, Authorized – 5,000 shares; Issued – 2,793 shares; 2,766 shares; – Outstanding – 2,790 shares; 2,763 shares, on each respective date 6,983 6,915
Additional paid-in-capital 4,107 3,807
Retained earnings 29,704 34,149
Accumulated other comprehensive loss (3,736) (3,577)
Common stock in treasury, at cost, 3 shares, on each respective date (53) (53)
Total Kewaunee Scientific Corporation Stockholders' Equity 37,005 41,241
Non-controlling interest 298 246
Total Stockholders' Equity 37,303 41,487
Total Liabilities and Stockholders' Equity $ 94,293 $ 89,384